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Abstract
Background: Opioid agonist maintenance treatment (OAMT) is a first-line treatment for heroin dependence, but its
effectiveness has been assessed primarily through clinical outcomes with a limited attention to patient perspectives.
Despite the increased use of patient reported outcome measures their patient-centeredness is highly questionable.
This is the protocol of a systematic review of qualitative research on how OAMT users construct the meaning of
their quality of life and well-being and a scoping review of instruments that measure these domains.
Methods: We will conduct a systematic review of qualitative research exploring the views of quality of life of
patients on OAMT (registration number CRD42018086490). According pre-specified eligibility criteria, we will
include studies from a comprehensive search of bibliographical databases from their inception. We will extract
data from included studies and assess their risk of bias with the CASP appraisal criteria, and will implement a
thematic analysis to generate a set of interpretative analytical themes ascertaining their confidence using the
CERQual approach. We will implement similar methods to conduct a scoping review to assess to what extent
the existing measures of these domains were focused on user’s views, assessing their validity using the
COSMIN methodology, and summarizing their characteristics and level of patient centeredness.
Conclusion: The findings from the reviews will contribute to obtain a genuine understanding of the perspective from
users on OAMT regarding their perception of well-being and quality of life and will likely lead to greater patient
centeredness when assessing such variables, which in turn may contribute to a more patient-centered care.
Keywords: Opioid maintenance treatment, Quality of life, Well-being, First-person perspective, Qualitative research,
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Background
Nowadays opioid agonist maintenance treatment (OAMT)
is a first-line psychopharmacological treatment for heroin
dependence [1]. Numerous studies have consistently
shown that OAMT is an effective treatment for opioid de-
pendence [2–6]. However, the effectiveness of OAMT has
been assessed primarily—indeed, almost exclusively—
through clinical outcomes or “hard” indicators [7], such as
treatment retention, reduction of heroin or other non-
prescribed opioids use, a reduction of morbidity and mor-
tality, and decreases in criminality, among others. While
these outcomes and indicators are valid and should be
assessed—especially in efficacy studies—they are often
used to justify health care policies or to seek community
approval. Moreover, such indicators are based on a nega-
tive and disorder-centered conception of health [7] (see
Additional file 1 Table S1).
The selection and assessment of the outcomes used to
evaluate the effect of interventions (such as OAMT) in
the field of addictive disorders remains challenging, not
only in the setting of clinical trials but particularly in
routine clinical practice [8–10]. Nevertheless, the role of
the patient perspective in such selection process has re-
ceived little attention. At present, assessment of OAMT
efficacy and effectiveness primarily focuses on outcomes
defined by the scientific and clinical community, and
these variables may not adequately reflect the patient’s
perspective, or they may not assess the outcomes in a
way that is relevant to them.
The most developed line of research in exploring the
OAMT patient’s perspective is focused on quality of life
or, in a broader approach, on the well-being construct,
since both terms are often used interchangeably [11, 12].
A growing number of authors, both in the field of ad-
dictive disorders [13, 14] and in other areas of health
care [15, 16], have questioned whether the scales most
commonly used to assess QoL or well-being actually
provide a truly patient-centered evaluation of this con-
struct. In this respect, De Maeyer and collaborators ex-
plored the nature and dimensions of this construct from
the perspective of patients receiving treatment for opioid
dependence [17]. The study showed that patients do not
primarily associate QOL with health, and moreover, they
spontaneously reported many more issues than those
usually included in the instruments commonly used to
assess QoL in these patients. Similarly, a recent QOL in-
strument developed with significant input from OAMT
patients did not include items on physical health [18].
In fact, in certain areas of health outcomes research
[19–21], there seems to be a growing consensus that
patients should be significantly involved—through truly
participatory methods—in developing any new patient-
reported outcome measure (PROM). The development of
new PROMs, however, should not be promoted without
synthetizing the existing knowledge allowing its applica-
tion to practice and the process of decision-making and
avoiding the production of research of little value [22–24].
However, to date—and despite a certain shift in how
OAMT results are evaluated, with a greater emphasis on
including patient perspectives—we still lack accurate re-
views to evaluate the extent to which patient perspectives
have been incorporated into the development of instru-
ments evaluating QoL and well-being in patients on
OAMT and to obtain an integrated and interpretative rep-
resentation of how these meanings are constructed from
the OAMT patient’s perspective. The application of know-
ledge to action framework should allow to implement
such syntheses of the existing knowledge in the elabor-
ation of QoL and well-being assessment tools genuinely
generated by patients [24, 25].
Given this context, here, we propose two interrelated
studies whose main aims are to, at least partially, address
the knowledge gap in this area and to remedy the pau-
city of patient-centered insight to assess QoL and well-
being in patients on OAMT. Our aim is to conduct a
systematic review of qualitative research on how OAMT
users perceive, experience and construct their quality of
life and well-being and a scoping review of instruments
that measure this domain.
Methods
We selected two specific methods for conducting know-
ledge synthesis adapted to the scope and nature of the
topic of interest (how quality of life (QoL) and well-being
have been defined from OAMT users’ views), which are
described below. The systematic review of qualitative re-
search will allow us to increase understanding of the
phenomenon of interest and its complexity [26], and the
scoping review will explore the extent, range, and charac-
teristics of existing measures for the aforementioned do-
mains [27]. We adhered the PRISMA-P guideline to
report this protocol (provided in the Additional file 2).
Study 1: Systematic review of qualitative research
We will conduct a systematic review of qualitative re-
search exploring OAMT users’ views and perspectives
on QoL to synthesize them into an integrated and inter-
pretative representation [28]. We have prepared a proto-
col following methodological standards [29] and
according to specific guidance to synthesize qualitative
research [26, 30, 31], that was publicly registered in
PROSPERO [32] (registration number
CRD42018086490). We will report the review findings
endorsing the ENTREQ reporting guidelines [33].
Inclusion criteria
The review will include studies focusing on individuals
diagnosed with opioid dependence disorder (according
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to the current version of either the Diagnostic and Stat-
istical Manual of Mental Disorders (DSM) or Inter-
national Classification of Diseases and Related Health
Problems (ICD) diagnostic systems) and who are receiv-
ing – or have recently received – OAMT. Eligible
studies will focus on their views, experiences and per-
spectives about the construct of interest, considering
those studies that have used the phenomenological per-
spective of a qualitative research.
Search methods to identify studies
We will perform a search in MEDLINE (Ovid), EMBASE
(Ovid), CINAHL (EBSCOHost), PsycINFO (Ovid), and
Cork database (Project Cork) from their inception. We
will design a search strategy combining terms related to
the inclusion criteria as well as controlled vocabulary re-
lated to these terms [for the strategy designed to search
MEDLINE see Additional file 3]. The search algorithms
will be adapted to the specific requirements of each spe-
cific database. We will execute the searches in these da-
tabases with no limitations other than language
(restricted to English, French, German, Dutch and Span-
ish) and the use of validated filters to obtain qualitative
research [34–37].
In addition to the search in databases we will identify
studies from the reference lists from the studies initially
included in our review, and will search unpublished
studies in Open Access Theses and Dissertations, Pro-
Quest Dissertations & Theses Database and through a
specific search in Google Scholar. Besides, we will track
references of additional studies citing the eligible studies
using the Web of Science.
Study selection and data collection
We will manage the search results using a reference
manager software. Two researchers will independently
screen the references’ titles and abstracts against the in-
clusion criteria, obtaining a copy of eligible studies to
determine their final inclusion. We will describe the en-
tire eligibility and selection process into a PRISMA flow-
chart and report the reasons for exclusion of ineligible
studies in a specific table.
Although the optimal approach to identifying sources
of bias in a qualitative study is a matter of discussion
[38–40], there is guidance to use approaches focusing at
least on the clarity of the study aims and its research
question, the congruence between aims and research de-
sign and methodology, the rigour in sampling and case
identification, and the appropriateness of the application
of the method, conceptual depth of findings, exploration
of deviant cases, and reflexivity of the researchers [41].
The Critical Appraisal Skills Programme (CASP) ap-
praisal criteria are the most commonly used for this pur-
pose and so we will use these criteria to assess the
studies included in the systematic review of qualitative
research [42].
We will extract data in two stages. First, we will ex-
tract study design and descriptive information and then,
we will extract quotes and categories identified through
the included studies' findings. Data collection in this sec-
ond part will be iterative, and we will revisit the texts to
compare ideas and original findings in light of any new
data identified [43–45].
We will pilot a pre-defined data extraction form ap-
praising at least three studies to verify the structure of
the form and the suitability of the process.
Data analysis and synthesis of findings
We will use an integrative and interpretative approach
for the findings from the systematic review of qualitative
research through a continuous comparison of results
from the original studies, implementing a thematic ana-
lysis standardized methodology [44, 45]. Based on the
data collected from the studies, we will code emerging
themes and iteratively compare them to recurring or
new themes identified in other studies. Through the
continuous comparison of data we will revisit previously
reviewed studies to delimit potential thematic overlap
and develop descriptive themes to finally generate con-
textualized, reflective and trustworthy analytical themes
[43–45].
Assessment of confidence in the findings of the review
We will use the Confidence in the Evidence from Re-
views of Qualitative research (CERQual) approach as a
structured and explicit method to ascertain the confi-
dence level that can be placed in the findings from the
systematic review of qualitative research [46]. For each
of the findings obtained in the thematic analysis, we will
assess the following determinants of their confidence:
methodological limitations; relevance (of the findings in
the context of the research question); coherence (of the
data to substantiate the explanation of phenomenon)
and adequacy (of the data in terms of their quantity and
richness in supporting the finding). Depending on the
evaluation of each of these domains, the confidence level
for each finding will be classified as high, moderate, low,
or very low. A summary table will provide the findings
of the review, the explanation or interpretation of those
findings, the confidence classification, and an explan-
ation of the criteria used to determine this classification.
Study 2: Scoping review of measuring instruments of
quality of life
In addition to the systematic review of qualitative re-
search we will also conduct a scoping review to deter-
mine how and to what extent the patients' perspective
has been incorporated into the development process of
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the measures used to evaluate QoL and well-being in pa-
tients on OAMT. We prepared a protocol according to
standardized guidance [47], which is publicly available at
Open Science Framework (https://osf.io/2cks9/). We will
conduct the scoping review in accordance to the meth-
odological framework proposed by Arksey and O'Malley
to conduct a scoping review [47–49]. We will report the
results of the scoping review according the correspond-
ing PRISMA extension [27].
Inclusion criteria
We will consider for inclusion psychometric and /or de-
velopment studies of instruments measuring QoL or
well-being in patients which have been diagnosed with
opioid dependence disorder according accepted diagnos-
tic classification criteria and had been receiving OAMT.
Search methods to identify studies
We will conduct searches according to the methodology
described for the systematic review of qualitative re-
search [see Additional file 3 for the detailed MEDLINE
search strings] but using a validated filter to obtain
PROMs [50].
Study selection and data collection
After exporting search results to a reference manager
software, two researchers will independently screen titles
and abstracts and obtain copies of eligible studies to de-
cide their inclusion in a process that will be detailed into
a PRISMA flowchart.
We will design a data extraction form to collect study’s
descriptive data and instruments’ characteristics according
to: (a) the instrument type [OAMT specific, focused on
the treatment of addictive disorders, or generic]; (b) its
content validity, relevance, comprehensiveness and
comprehensibility assessed using the COnsensus-based
Standards for the selection of health Measurement INstru-
ments (COSMIN) methodology [51]; (c) factor structure
[global or unidimensional measures, or multidimensional
instruments]; and (d) the extent to which patient perspec-
tives are incorporated into the instrument, based on the
level of patient involvement. We will assess patient in-
volvement (i.e., consultation, contribution, collaboration,
or control [52]) during all the stages of the tool's develop-
ment: (a) conceptualization of the construct to be mea-
sured and determination of the domains to be assessed;
(b) item generation; (c) evaluation of item relevance, com-
prehensiveness and comprehensibility; and (d) psychomet-
ric analysis.
Data analysis and synthesis of findings
We will integrate the characteristics included instru-
ments, their content validity, the degree of patient
centeredness, and the domains assessed following a
thematic analysis framework [44], mapping the find-
ings in accordance with the study objectives [47].
Utility and applicability of the findings
Once the findings of the scoping review have been ob-
tained, a consultation process will be performed [48, 49]
in which patients receiving OAMT will be contacted and
asked to provide their views of these findings.
Discussion
In this paper we describe the protocol of a systematic re-
view of qualitative research to obtain a genuine under-
standing of the perspective from users on opioid agonist
maintenance treatments (OAMT) regarding their per-
ception of well-being and quality of life (QoL), as well as
a scoping review to assess to what extent the existing
measures of these domains were focused on user’s views.
Applying a knowledge transfer framework [24, 25], the
findings from these reviews will inform the drafting of
the items of a patient-centered QoL scale that will be
constructed according to measures development stan-
dards [53, 54]
The improvement and evaluation of processes and
outcomes of care should be open to a broad approach
that may reflect patient’s voice and perspectives. It
has been hypothesized that patient reported outcomes
(PROMs) improve patient’s skills at identifying, bring-
ing meaning and describing health states. Shifting dis-
cussion into patients’ perspectives improves their
functioning because it addresses some of their funda-
mental needs, enables them at constructing messages
about their health state, and allows healthcare profes-
sionals to improve their understanding about these
health states [55].
The measurement of relevant outcomes entails the
challenge to evaluate processes of care focusing beyond
the effectiveness of a determinate intervention, and
broadening the perspective to the patient perception of
its benefits or the response to treatment. PROMs have
shown some positive impact in processes of care such as
diagnosis, monitoring progression of disease or manage-
ment of health conditions and response to treatment
[56, 57]. These findings are specifically consistent in the
field of mental health [58]. PROMs also constitute a pre-
sumably effective method to enhance the communica-
tion at medical encounter [59].
On the other hand, PROMs face some practical
challenges hindering their ability to truly focus on pa-
tient perspective: who decides what to include and
what to emphasize in such measures or, in other
words, whether they reflect a true representation of
patient experience [57]. Despite their potential con-
tent validity and relevance for respondents many
PROMs have been developed without direct patient
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participation thus threatening the instruments’ cap-
acity to be sensible to patients’ needs, priorities and
preferences [13, 58]. For these reasons the develop-
ment of measures that are truly representative of pa-
tient’s views and experiences should entail an
understanding and capacity to capture their nuances
and complexity.
Grounded in the knowledge to action framework
[25], we plan to conduct a study to adapt and tailor
the existing research on the views of patients that are
on OAMT about QoL and well-being and implement
this knowledge in the development of a patient-
centered instrument. To ease the implementation of
existing knowledge we are convinced of the role of
syntheses of qualitative research in achieving a better
understanding of complexity and subjectivity [28, 31].
The scoping review will also contribute to identify the
key approaches already existing in the literature to
the domain of interest and to define gaps in this area.
For that reason we will conduct a review of qualita-
tive studies to obtain a contextualized and reflective
representation of OAMT patients’ views of QoL and
well-being. Furthermore we will use the CERQual ap-
proach to assess the confidence in the synthesis find-
ings [46] and we will use the findings with the
highest confidence as a reliable representation of
patients’ views that could serve to draft items of the
initial version of the scale. Pursuing triangulation of
data, we will try to gain in comprehensiveness by col-
lecting additional information from truly patient-
centered measurement instruments identified from a
scoping review.
At the end we will be able to compile a body of evi-
dence to genuinely grasp the perspective from patients
on OAMT regarding their perception of well-being and
QoL. We firmly consider that such knowledge is likely
to lead to greater patient centeredness in considering
QoL and well-being in OAMT, which in turn may con-
tribute to a more patient-centered care for opioid-
dependent patients in agonist maintenance treatment
[60–62].
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